Millendo Therapeutics, Inc. logo

Millendo Therapeutics, Inc. MLND

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

1.27 M

Market Cap[1]

$ 20.2 M

EBITDA (LTM)

$ 1.05 B

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Фармсинтез Фармсинтез
LIFE
- - - MOEX russiaRussia
Atara Biotherapeutics Atara Biotherapeutics
ATRA
$ 6.85 5.38 % $ 85.9 M Nasdaq Global Select Market,SPB usaUSA
Oncternal Therapeutics Oncternal Therapeutics
ONCT
- -24.12 % $ 1.56 M Nasdaq Capital Market usaUSA
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
$ 1.09 -19.26 % $ 34 M NYSE American usaUSA
Axon Enterprise Axon Enterprise
AXON
$ 300.63 0.68 % $ 23.5 B Nasdaq Global Select Market,SPB usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
MannKind Corporation MannKind Corporation
MNKD
$ 4.08 0.12 % $ 1.25 B Nasdaq Global Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
- - $ 401 M Nasdaq Global Market usaUSA
Histogen Histogen
HSTO
- 31.6 % $ 2.12 M Nasdaq Global Select Market usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
- - $ 1.62 B NYSE israelIsrael
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
- 7.4 % $ 6.29 M Nasdaq Global Market usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
- - $ 958 M Nasdaq Global Market usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
- - $ 8.14 B Nasdaq Global Select Market,SPB usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
- - $ 26.6 B Nasdaq Global Select Market irlandaIrlanda
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 1.48 -3.27 % $ 2.44 M NYSE American israelIsrael
Provention Bio Provention Bio
PRVB
- - $ 2.37 B Nasdaq Global Select Market usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
$ 119.1 2.14 % $ 7.74 B Nasdaq Global Market,SPB usaUSA
iTeos Therapeutics iTeos Therapeutics
ITOS
- - $ 411 M Nasdaq Global Market usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
$ 2.76 -8.35 % $ 36.8 M Nasdaq Global Market usaUSA
PolarityTE PolarityTE
PTE
- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Kronos Bio Kronos Bio
KRON
- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Cullinan Management Cullinan Management
CGEM
$ 9.01 -2.86 % $ 543 M Nasdaq Global Select Market usaUSA
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
$ 54.13 2.46 % $ 151 M Nasdaq Global Select Market israelIsrael
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Trevena Trevena
TRVN
- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Molecular Templates Molecular Templates
MTEM
- -23.43 % $ 495 K Nasdaq Capital Market usaUSA
Oncorus Oncorus
ONCR
- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
$ 0.07 9.81 % $ 855 K Nasdaq Global Select Market,SPB usaUSA
Novan Novan
NOVN
- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
CohBar CohBar
CWBR
- -15.44 % $ 2.2 M Nasdaq Capital Market usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
- -1.56 % $ 12.3 M Nasdaq Global Select Market usaUSA
Epizyme Epizyme
EPZM
- - $ 249 M Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
- -48.37 % $ 3.71 M Nasdaq Global Select Market usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
- - $ 4.55 M Nasdaq Global Select Market irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
$ 0.81 9.63 % $ 16.6 M NYSE American usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
- - $ 218 M Nasdaq Global Select Market usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
$ 3.02 -2.27 % $ 128 M Nasdaq Capital Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
- - $ 105 M Nasdaq Global Market usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
$ 0.52 -0.62 % $ 5.75 M Nasdaq Capital Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
- - $ 4.62 B Nasdaq Global Select Market,SPB usaUSA
Inozyme Pharma Inozyme Pharma
INZY
- - $ 207 M Nasdaq Global Select Market usaUSA
NanoString Technologies NanoString Technologies
NSTG
- -37.43 % $ 5.1 M Nasdaq Global Select Market usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.36 5.82 % $ 2.83 M Nasdaq Global Market israelIsrael
Humanigen Humanigen
HGEN
- -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.